	US 11,696,595 B2
	Maternal supplement
Clara Lucia Garcia-Rodenas, Forel (CH); and Michael Affolter, Savigny (CH)
Assigned to Societe des Produits Nestle S.A., Vevey (CH)
Appl. No. 16/768,829
Filed by SOCIETE DES PRODUITS NESTLE S.A., Vevey (CH)
PCT Filed Nov. 29, 2018, PCT No. PCT/EP2018/082923 § 371(c)(1), (2) Date Jun. 1, 2020, PCT Pub. No. WO2019/106060, PCT Pub. Date Jun. 6, 2019.
Claims priority of application No. 17205002 (EP), filed on Dec. 1, 2017.
Prior Publication US 2021/0169114 A1, Jun. 10, 2021
Int. Cl. A61K 33/00 (2006.01); A23L 33/155 (2016.01); A61K 31/07 (2006.01); A61K 31/355 (2006.01); A61K 31/455 (2006.01); A61K 33/04 (2006.01); A61K 33/30 (2006.01)

CPC A23L 33/155 (2016.08) [A61K 31/07 (2013.01); A61K 31/355 (2013.01); A61K 31/455 (2013.01); A61K 33/04 (2013.01); A61K 33/30 (2013.01)]

11 Claims

1. A method of providing a maternal composition to a woman who is at risk of giving birth prematurely and desiring to get pregnant, the method comprising administering the maternal composition to the woman, wherein the maternal composition comprises one selected from the group consisting of selenium, zinc, tocopherol, retinol, nicotinic acid, and combinations thereof.